Cargando…
Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia
OBJECTIVES: This study aimed to report the rate of thyroid malignancy in benign fine-needle aspirations (Bethesda II) at King Abdulaziz Medical City and evaluate the factors that affect false-negative outcomes of FNA. METHODS: All patients referred for thyroidectomy from 2009 to 2019 were reviewed (...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330754/ https://www.ncbi.nlm.nih.gov/pubmed/35880364 http://dx.doi.org/10.14639/0392-100X-N1903 |
_version_ | 1784758238959370240 |
---|---|
author | Al Essa, Mohammed Doubi, Aseel Aldosari, Lama Alkhaldi, Abdullah Alzahrani, Manar Alsadi, Mada Alsalem, Abdulaziz |
author_facet | Al Essa, Mohammed Doubi, Aseel Aldosari, Lama Alkhaldi, Abdullah Alzahrani, Manar Alsadi, Mada Alsalem, Abdulaziz |
author_sort | Al Essa, Mohammed |
collection | PubMed |
description | OBJECTIVES: This study aimed to report the rate of thyroid malignancy in benign fine-needle aspirations (Bethesda II) at King Abdulaziz Medical City and evaluate the factors that affect false-negative outcomes of FNA. METHODS: All patients referred for thyroidectomy from 2009 to 2019 were reviewed (n = 1968). Only patients with a benign FNA, corresponding to the Bethesda II, were included (n = 384). Information on age, gender, body mass index (BMI), serum thyroid-stimulating hormone, type of surgery and histopathological outcomes were retrieved. RESULTS: Of the sample (n = 384) with an initial benign FNA, 63 patients had a malignancy on postoperative pathological examination, yielding an overall false-negative rate of 16.4%. The most frequently reported histopathological type was papillary thyroid microcarcinomas (n = 52). For the false-negative group, the mean age was 43.8 years (range 21-70 years) with an 84.1% female predominance. The surgical choice for 74% (n = 46) of cases was total thyroidectomy. Age, gender, thyroid function and BMI did not affect the false-negative rate of benign FNA (p > 0.05). CONCLUSIONS: This study found a higher risk of malignancy compared to the literature related to benign FNA. The risk of malignancy should be considered, even with benign FNA. |
format | Online Article Text |
id | pubmed-9330754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Pacini Editore Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-93307542022-08-09 Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia Al Essa, Mohammed Doubi, Aseel Aldosari, Lama Alkhaldi, Abdullah Alzahrani, Manar Alsadi, Mada Alsalem, Abdulaziz Acta Otorhinolaryngol Ital Thyroid OBJECTIVES: This study aimed to report the rate of thyroid malignancy in benign fine-needle aspirations (Bethesda II) at King Abdulaziz Medical City and evaluate the factors that affect false-negative outcomes of FNA. METHODS: All patients referred for thyroidectomy from 2009 to 2019 were reviewed (n = 1968). Only patients with a benign FNA, corresponding to the Bethesda II, were included (n = 384). Information on age, gender, body mass index (BMI), serum thyroid-stimulating hormone, type of surgery and histopathological outcomes were retrieved. RESULTS: Of the sample (n = 384) with an initial benign FNA, 63 patients had a malignancy on postoperative pathological examination, yielding an overall false-negative rate of 16.4%. The most frequently reported histopathological type was papillary thyroid microcarcinomas (n = 52). For the false-negative group, the mean age was 43.8 years (range 21-70 years) with an 84.1% female predominance. The surgical choice for 74% (n = 46) of cases was total thyroidectomy. Age, gender, thyroid function and BMI did not affect the false-negative rate of benign FNA (p > 0.05). CONCLUSIONS: This study found a higher risk of malignancy compared to the literature related to benign FNA. The risk of malignancy should be considered, even with benign FNA. Pacini Editore Srl 2022-06-30 2022-06 /pmc/articles/PMC9330754/ /pubmed/35880364 http://dx.doi.org/10.14639/0392-100X-N1903 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en |
spellingShingle | Thyroid Al Essa, Mohammed Doubi, Aseel Aldosari, Lama Alkhaldi, Abdullah Alzahrani, Manar Alsadi, Mada Alsalem, Abdulaziz Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title | Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title_full | Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title_fullStr | Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title_full_unstemmed | Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title_short | Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia |
title_sort | risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in riyadh, saudi arabia |
topic | Thyroid |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330754/ https://www.ncbi.nlm.nih.gov/pubmed/35880364 http://dx.doi.org/10.14639/0392-100X-N1903 |
work_keys_str_mv | AT alessamohammed riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT doubiaseel riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT aldosarilama riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT alkhaldiabdullah riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT alzahranimanar riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT alsadimada riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia AT alsalemabdulaziz riskofthyroidcarcinomainpatientstreatedsurgicallywithassumedbenigncytologyinriyadhsaudiarabia |